Acer Therapeutics Inc (NASDAQ:ACER)

17.37
Delayed Data
As of Feb 16
 +0.46 / +2.72%
Today’s Change
5.70
Today|||52-Week Range
22.63
+25.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-16.7M-15.1M-12.0M-8.0M
 
 
 
 
 
Depreciation335.6K387.8K351.4K238.1K
 
 
 
 
 
Total Other Cash Flow5.3M1.3M915.1K1.8M
 
 
 
 
 
Funds From Operations-11.0M-13.4M-10.8M-6.0M
 
 
 
 
 
Funds From/For Other Operating Expenses-4.9M797.0K-241.1K3.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-6.1M-14.2M-10.5M-9.2M
 
 
 
 
 
 
InvestingCapital Expenditures-259.2K-190.9K-92.3K-1.2K
 
 
 
 
 
Other Investing - Sources1.0M0.000.000.00
 
 
Net Cash Flow Investing740.8K-190.9K-92.3K-1.2K
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.00---186.7K
 
 
Long Term Borrowings502.2K0.000.00-82.8K
 
 
 
Long Term Debt Reduction-550.0K0.000.000.00
 
 
Net Proceeds Stock Sale28.5M648.2K13.3M334.9K
 
 
 
 
 
Common Preferred Redeemed0.000.00-5.0K0.00
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing28.4M648.2K13.3M65.4K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00------
 
Net Change In Cash23.1M-13.7M2.7M-9.1M